US Stock MarketDetailed Quotes

OM Outset Medical

Watchlist
  • 1.210
  • +0.100+9.01%
Close Dec 20 16:00 ET
  • 1.150
  • -0.060-4.96%
Post 20:01 ET
63.58MMarket Cap-0.44P/E (TTM)

Outset Medical Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Quarterly+Annual
YOY yoy
Hide blank lines yoy
(Q3)Sep 30, 2024
(Q2)Jun 30, 2024
(Q1)Mar 31, 2024
(FY)Dec 31, 2023
(Q4)Dec 31, 2023
(Q3)Sep 30, 2023
(Q2)Jun 30, 2023
(Q1)Mar 31, 2023
(FY)Dec 31, 2022
(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities
39.50%-20.57M
-18.31%-33.34M
-2.58%-45.91M
9.85%-131.37M
29.17%-24.44M
0.91%-34M
26.96%-28.18M
-16.75%-44.76M
-11.87%-145.73M
-5.60%-34.51M
Net income from continuing operations
39.50%-27.94M
21.78%-34.45M
9.16%-39.94M
-6.04%-172.8M
6.86%-38.6M
-13.24%-46.18M
-0.47%-44.05M
-19.19%-43.97M
-23.51%-162.96M
-0.51%-41.44M
Operating gains losses
-15.38%11K
----
----
----
----
--13K
----
----
--1.37M
----
Depreciation and amortization
-5.12%1.39M
-2.84%1.47M
5.49%1.46M
12.40%5.81M
13.95%1.45M
11.57%1.47M
14.35%1.51M
9.67%1.38M
0.14%5.17M
-2.08%1.27M
Other non cash items
30.94%1.02M
27.28%989K
28.65%952K
115.72%3.39M
273.04%1.09M
84.16%779K
75.40%777K
79.61%740K
-6.04%1.57M
-39.21%293K
Change In working capital
-145.10%-414K
-333.42%-11.9M
-43.55%-15.46M
96.34%-773K
207.31%3.98M
125.84%918K
210.92%5.1M
-15.95%-10.77M
17.42%-21.14M
-498.49%-3.71M
-Change in receivables
-110.26%-139K
120.19%544K
43.81%-3.5M
-103.27%-5.09M
144.23%2.47M
-35.93%1.36M
-219.09%-2.7M
-379.14%-6.22M
86.90%-2.51M
11.34%-5.59M
-Change in inventory
106.42%225K
-292.32%-6.23M
-342.99%-6.98M
111.18%1.65M
-132.41%-960K
-47.29%-3.51M
129.13%3.24M
168.67%2.87M
33.17%-14.73M
171.95%2.96M
-Change in prepaid assets
186.24%652K
154.55%1.6M
-170.30%-400K
160.82%739K
115.39%299K
-214.89%-756K
1,035.82%627K
315.33%569K
-165.32%-1.22M
-270.14%-1.94M
-Change in payables and accrued expense
-108.41%-350K
-409.86%-7.64M
32.66%-5.4M
107.21%267K
416.25%1.65M
213.80%4.16M
-33.06%2.46M
-98.15%-8.01M
-131.60%-3.7M
-96.50%320K
-Change in other current liabilities
-26.40%-407K
-18.35%-387K
-21.09%-379K
-17.13%-1.35M
-25.82%-385K
-8.78%-322K
-18.05%-327K
-15.50%-313K
-30.39%-1.15M
-15.47%-306K
-Change in other working capital
-2,368.75%-395K
-88.09%213K
251.03%1.2M
39.52%3.02M
6.50%901K
-260.00%-16K
92.37%1.79M
-9.07%341K
-24.99%2.16M
-36.44%846K
Cash from discontinued investing activities
Operating cash flow
39.50%-20.57M
-18.31%-33.34M
-2.58%-45.91M
9.85%-131.37M
29.17%-24.44M
0.91%-34M
26.96%-28.18M
-16.75%-44.76M
-11.87%-145.73M
-5.60%-34.51M
Investing cash flow
Cash flow from continuing investing activities
-46.74%15.88M
43.41%38.94M
-2,333.48%-59.03M
225.24%83.03M
145.27%23.43M
47.85%29.81M
2,163.30%27.15M
107.92%2.64M
53.48%-66.3M
-215.19%-51.75M
Net PPE purchase and sale
49.49%-395K
84.91%-120K
56.30%-354K
58.68%-3.44M
50.07%-1.05M
71.47%-782K
60.19%-795K
45.20%-810K
-167.86%-8.33M
-147.83%-2.11M
Net investment purchase and sale
-46.81%16.27M
39.76%39.06M
-1,799.30%-58.68M
249.16%86.47M
149.31%24.48M
33.57%30.59M
4,003.96%27.95M
110.82%3.45M
58.41%-57.97M
-218.87%-49.64M
Cash from discontinued investing activities
Investing cash flow
-46.74%15.88M
43.41%38.94M
-2,333.48%-59.03M
225.24%83.03M
145.27%23.43M
47.85%29.81M
2,163.30%27.15M
107.92%2.64M
53.48%-66.3M
-215.19%-51.75M
Financing cash flow
Cash flow from continuing financing activities
-97.05%121K
-92.62%77K
1,200.17%68.61M
-40.12%43.65M
-49.35%33.23M
61.98%4.1M
0.10%1.04M
41.74%5.28M
-54.48%72.9M
6,923.55%65.6M
Net issuance payments of debt
--0
--0
--66.52M
-48.77%33.23M
--33.23M
--0
--0
--0
--64.86M
----
Net common stock issuance
----
----
----
--0
----
----
----
----
--0
----
Proceeds from stock option exercised by employees
-97.05%121K
-92.62%77K
-60.47%2.09M
29.66%10.43M
-99.34%4K
53.79%4.1M
0.10%1.04M
41.74%5.28M
-27.30%8.04M
-34.80%609K
Cash from discontinued financing activities
Financing cash flow
-97.05%121K
-92.62%77K
1,200.17%68.61M
-40.12%43.65M
-49.35%33.23M
61.98%4.1M
0.10%1.04M
41.74%5.28M
-54.48%72.9M
6,923.55%65.6M
Net cash flow
Beginning cash position
3.70%41.19M
-10.56%35.51M
-6.13%71.84M
-64.51%76.53M
-59.23%39.63M
-63.50%39.72M
-73.12%39.7M
-64.51%76.53M
-34.31%215.66M
-63.16%97.19M
Current changes in cash
-4,924.18%-4.57M
28,315.00%5.68M
1.37%-36.33M
96.63%-4.7M
255.95%32.21M
99.22%-91K
100.05%20K
45.83%-36.84M
-23.53%-139.13M
57.11%-20.66M
End cash Position
-7.60%36.62M
3.70%41.19M
-10.56%35.51M
-6.13%71.84M
-6.13%71.84M
-59.23%39.63M
-63.50%39.72M
-73.12%39.7M
-64.51%76.53M
-64.51%76.53M
Free cash flow
39.73%-20.96M
-15.48%-33.46M
-1.54%-46.27M
12.49%-134.81M
30.37%-25.5M
6.13%-34.78M
28.59%-28.97M
-14.45%-45.57M
-15.51%-154.05M
-9.21%-36.62M
Currency Unit
USD
USD
USD
USD
USD
USD
USD
USD
USD
USD
Accounting Standards
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
US-GAAP
(Q3)Sep 30, 2024(Q2)Jun 30, 2024(Q1)Mar 31, 2024(FY)Dec 31, 2023(Q4)Dec 31, 2023(Q3)Sep 30, 2023(Q2)Jun 30, 2023(Q1)Mar 31, 2023(FY)Dec 31, 2022(Q4)Dec 31, 2022
Operating Cash Flow (Indirect Method)
Cash flow from continuing operating activities 39.50%-20.57M-18.31%-33.34M-2.58%-45.91M9.85%-131.37M29.17%-24.44M0.91%-34M26.96%-28.18M-16.75%-44.76M-11.87%-145.73M-5.60%-34.51M
Net income from continuing operations 39.50%-27.94M21.78%-34.45M9.16%-39.94M-6.04%-172.8M6.86%-38.6M-13.24%-46.18M-0.47%-44.05M-19.19%-43.97M-23.51%-162.96M-0.51%-41.44M
Operating gains losses -15.38%11K------------------13K----------1.37M----
Depreciation and amortization -5.12%1.39M-2.84%1.47M5.49%1.46M12.40%5.81M13.95%1.45M11.57%1.47M14.35%1.51M9.67%1.38M0.14%5.17M-2.08%1.27M
Other non cash items 30.94%1.02M27.28%989K28.65%952K115.72%3.39M273.04%1.09M84.16%779K75.40%777K79.61%740K-6.04%1.57M-39.21%293K
Change In working capital -145.10%-414K-333.42%-11.9M-43.55%-15.46M96.34%-773K207.31%3.98M125.84%918K210.92%5.1M-15.95%-10.77M17.42%-21.14M-498.49%-3.71M
-Change in receivables -110.26%-139K120.19%544K43.81%-3.5M-103.27%-5.09M144.23%2.47M-35.93%1.36M-219.09%-2.7M-379.14%-6.22M86.90%-2.51M11.34%-5.59M
-Change in inventory 106.42%225K-292.32%-6.23M-342.99%-6.98M111.18%1.65M-132.41%-960K-47.29%-3.51M129.13%3.24M168.67%2.87M33.17%-14.73M171.95%2.96M
-Change in prepaid assets 186.24%652K154.55%1.6M-170.30%-400K160.82%739K115.39%299K-214.89%-756K1,035.82%627K315.33%569K-165.32%-1.22M-270.14%-1.94M
-Change in payables and accrued expense -108.41%-350K-409.86%-7.64M32.66%-5.4M107.21%267K416.25%1.65M213.80%4.16M-33.06%2.46M-98.15%-8.01M-131.60%-3.7M-96.50%320K
-Change in other current liabilities -26.40%-407K-18.35%-387K-21.09%-379K-17.13%-1.35M-25.82%-385K-8.78%-322K-18.05%-327K-15.50%-313K-30.39%-1.15M-15.47%-306K
-Change in other working capital -2,368.75%-395K-88.09%213K251.03%1.2M39.52%3.02M6.50%901K-260.00%-16K92.37%1.79M-9.07%341K-24.99%2.16M-36.44%846K
Cash from discontinued investing activities
Operating cash flow 39.50%-20.57M-18.31%-33.34M-2.58%-45.91M9.85%-131.37M29.17%-24.44M0.91%-34M26.96%-28.18M-16.75%-44.76M-11.87%-145.73M-5.60%-34.51M
Investing cash flow
Cash flow from continuing investing activities -46.74%15.88M43.41%38.94M-2,333.48%-59.03M225.24%83.03M145.27%23.43M47.85%29.81M2,163.30%27.15M107.92%2.64M53.48%-66.3M-215.19%-51.75M
Net PPE purchase and sale 49.49%-395K84.91%-120K56.30%-354K58.68%-3.44M50.07%-1.05M71.47%-782K60.19%-795K45.20%-810K-167.86%-8.33M-147.83%-2.11M
Net investment purchase and sale -46.81%16.27M39.76%39.06M-1,799.30%-58.68M249.16%86.47M149.31%24.48M33.57%30.59M4,003.96%27.95M110.82%3.45M58.41%-57.97M-218.87%-49.64M
Cash from discontinued investing activities
Investing cash flow -46.74%15.88M43.41%38.94M-2,333.48%-59.03M225.24%83.03M145.27%23.43M47.85%29.81M2,163.30%27.15M107.92%2.64M53.48%-66.3M-215.19%-51.75M
Financing cash flow
Cash flow from continuing financing activities -97.05%121K-92.62%77K1,200.17%68.61M-40.12%43.65M-49.35%33.23M61.98%4.1M0.10%1.04M41.74%5.28M-54.48%72.9M6,923.55%65.6M
Net issuance payments of debt --0--0--66.52M-48.77%33.23M--33.23M--0--0--0--64.86M----
Net common stock issuance --------------0------------------0----
Proceeds from stock option exercised by employees -97.05%121K-92.62%77K-60.47%2.09M29.66%10.43M-99.34%4K53.79%4.1M0.10%1.04M41.74%5.28M-27.30%8.04M-34.80%609K
Cash from discontinued financing activities
Financing cash flow -97.05%121K-92.62%77K1,200.17%68.61M-40.12%43.65M-49.35%33.23M61.98%4.1M0.10%1.04M41.74%5.28M-54.48%72.9M6,923.55%65.6M
Net cash flow
Beginning cash position 3.70%41.19M-10.56%35.51M-6.13%71.84M-64.51%76.53M-59.23%39.63M-63.50%39.72M-73.12%39.7M-64.51%76.53M-34.31%215.66M-63.16%97.19M
Current changes in cash -4,924.18%-4.57M28,315.00%5.68M1.37%-36.33M96.63%-4.7M255.95%32.21M99.22%-91K100.05%20K45.83%-36.84M-23.53%-139.13M57.11%-20.66M
End cash Position -7.60%36.62M3.70%41.19M-10.56%35.51M-6.13%71.84M-6.13%71.84M-59.23%39.63M-63.50%39.72M-73.12%39.7M-64.51%76.53M-64.51%76.53M
Free cash flow 39.73%-20.96M-15.48%-33.46M-1.54%-46.27M12.49%-134.81M30.37%-25.5M6.13%-34.78M28.59%-28.97M-14.45%-45.57M-15.51%-154.05M-9.21%-36.62M
Currency Unit USDUSDUSDUSDUSDUSDUSDUSDUSDUSD
Accounting Standards US-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAPUS-GAAP
Trending US Stocks
Fed Rate Cut Beneficiaries Fed Rate Cut Beneficiaries

Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data. Stocks that are expected to benefit from a Federal Reserve rate cut. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only. This section presents the top 5 stocks in Fed Rate Cut Beneficiaries, ranked from highest to lowest based on real-time market data.

Symbol Mini Chart % Chg
MicroStrategy
MSTR
+11.56%
Adobe
ADBE
+2.24%
Salesforce
CRM
+2.21%
Apple
AAPL
+1.88%
Meritage Homes
MTH
+1.78%

Unlock the Full List